These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 14751777

  • 1. Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody.
    Howe CL, Bieber AJ, Warrington AE, Pease LR, Rodriguez M.
    Neurobiol Dis; 2004 Feb; 15(1):120-31. PubMed ID: 14751777
    [Abstract] [Full Text] [Related]

  • 2. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
    Qin J, Sikkema AH, van der Bij K, de Jonge JC, Klappe K, Nies V, Jonker JW, Kok JW, Hoekstra D, Baron W.
    J Neurosci; 2017 Oct 11; 37(41):9925-9938. PubMed ID: 28899916
    [Abstract] [Full Text] [Related]

  • 3. The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination.
    Cui C, Wang J, Mullin AP, Caggiano AO, Parry TJ, Colburn RW, Pavlopoulos E.
    Brain Res; 2018 Sep 01; 1694():73-86. PubMed ID: 29775564
    [Abstract] [Full Text] [Related]

  • 4. Method of identifying natural antibodies for remyelination.
    Warrington AE, Rodriguez M.
    J Clin Immunol; 2010 May 01; 30 Suppl 1(0 1):S50-5. PubMed ID: 20387101
    [Abstract] [Full Text] [Related]

  • 5. Immunobiology of oligodendrocytes in multiple sclerosis.
    Ruffini F, Chojnacki A, Weiss S, Antel JP.
    Adv Neurol; 2006 May 01; 98():47-63. PubMed ID: 16400826
    [No Abstract] [Full Text] [Related]

  • 6. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.
    Watzlawik JO, Warrington AE, Rodriguez M.
    PLoS One; 2013 May 01; 8(2):e55149. PubMed ID: 23383310
    [Abstract] [Full Text] [Related]

  • 7. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
    Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ.
    Nature; 2015 Jun 11; 522(7555):216-20. PubMed ID: 25896324
    [Abstract] [Full Text] [Related]

  • 8. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP, Cui C, Wang Y, Wang J, Troy E, Caggiano AO, Parry TJ, Colburn RW, Pavlopoulos E.
    Neurobiol Dis; 2017 Sep 11; 105():142-155. PubMed ID: 28576706
    [Abstract] [Full Text] [Related]

  • 9. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair.
    Paz Soldán MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Rodriguez M.
    Mol Cell Neurosci; 2003 Jan 11; 22(1):14-24. PubMed ID: 12595235
    [Abstract] [Full Text] [Related]

  • 10. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ, Hasselmann J, Augello C, Moore S, Tiwari-Woodruff SK.
    J Steroid Biochem Mol Biol; 2016 Jun 11; 160():43-52. PubMed ID: 26776441
    [Abstract] [Full Text] [Related]

  • 11. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ.
    Glia; 2006 May 11; 53(7):696-703. PubMed ID: 16498619
    [Abstract] [Full Text] [Related]

  • 12. A recombinant human IgM promotes myelin repair after a single, very low dose.
    Warrington AE, Bieber AJ, Ciric B, Pease LR, Van Keulen V, Rodriguez M.
    J Neurosci Res; 2007 Apr 11; 85(5):967-76. PubMed ID: 17304578
    [Abstract] [Full Text] [Related]

  • 13. Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.
    Warrington AE, Rodriguez M.
    Curr Top Microbiol Immunol; 2008 Apr 11; 318():213-39. PubMed ID: 18219820
    [Abstract] [Full Text] [Related]

  • 14. Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis.
    Cid C, Alvarez-Cermeño JC, Salinas M, Alcázar A.
    J Neurochem; 2005 Oct 11; 95(2):349-60. PubMed ID: 16135098
    [Abstract] [Full Text] [Related]

  • 15. Developmental differences in HO-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3.
    Fragoso G, Martínez-Bermúdez AK, Liu HN, Khorchid A, Chemtob S, Mushynski WE, Almazan G.
    J Neurochem; 2004 Jul 11; 90(2):392-404. PubMed ID: 15228596
    [Abstract] [Full Text] [Related]

  • 16. Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma.
    Rosenbluth J, Schiff R, Liang WL, Dou W.
    J Neurocytol; 2003 Mar 11; 32(3):265-76. PubMed ID: 14724389
    [Abstract] [Full Text] [Related]

  • 17. Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
    Xiao L, Guo D, Hu C, Shen W, Shan L, Li C, Liu X, Yang W, Zhang W, He C.
    Glia; 2012 Jul 11; 60(7):1037-52. PubMed ID: 22461009
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.
    Tegla CA, Cudrici C, Rus V, Ito T, Vlaicu S, Singh A, Rus H.
    J Neuroimmunol; 2009 Aug 18; 213(1-2):3-11. PubMed ID: 19577811
    [Abstract] [Full Text] [Related]

  • 19. The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
    Wootla B, Watzlawik JO, Denic A, Rodriguez M.
    Expert Rev Clin Immunol; 2013 Jun 18; 9(6):535-49. PubMed ID: 23730884
    [Abstract] [Full Text] [Related]

  • 20. Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes.
    Watzlawik J, Holicky E, Edberg DD, Marks DL, Warrington AE, Wright BR, Pagano RE, Rodriguez M.
    Glia; 2010 Nov 15; 58(15):1782-93. PubMed ID: 20645409
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.